Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 4/20 | 0.56 |
| ▸ | SIRT5 | Q9NXA8 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.44 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.44 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.44 |
| ▸ | GNPAT | O15228 | 1/20 | 0.42 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.41 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29589379 | 0.87 | NPY4R (0.52) | FOLH1ERAP2ERAP1LNPEPNOD1 | |
| SCHEMBL30915565 | 0.86 | FOLH1 (0.61) | FOLH1SIRT5SMN1; SMN2NOD1GNPAT | |
| SCHEMBL27903157 | 0.85 | FOLH1 (0.47) | FOLH1ERAP2ERAP1LNPEPNOD1 | |
| SCHEMBL1711582 | 0.85 | FOLH1 (0.47) | FOLH1ERAP2ERAP1LNPEPNOD1 | |
| SCHEMBL29714926 | 0.85 | FOLH1 (0.47) | FOLH1ERAP2ERAP1LNPEPNOD1 | |
| SCHEMBL30919262 | 0.85 | FOLH1 (0.51) | FOLH1SIRT5SMN1; SMN2ALDH1A1NOD1 | |
| SCHEMBL13670128 | 0.84 | FOLH1 (0.56) | FOLH1SIRT5SMN1; SMN2NOD1SIRT6 | |
| SCHEMBL29394341 | 0.83 | FOLH1 (0.58) | FOLH1SIRT5SMN1; SMN2NOD1GNPAT | |
| SCHEMBL14075788 | 0.83 | FOLH1 (0.58) | FOLH1SIRT5SMN1; SMN2NOD1GNPAT | |
| SCHEMBL1711266 | 0.83 | ERAP2 (0.58) | FOLH1ERAP2ERAP1LNPEPNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684807-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-01-28 | — | — | EP | claimed |
| CN-119300868-A | Camptothecins compound and conjugate thereof, preparation method and application thereof | 映恩生物科技(上海)有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119053607-A | Camptothecins compound and conjugate thereof, preparation method and application thereof | 映恩生物科技(上海)有限公司 | 2024-11-29 | — | — | CN | claimed |
| WO-2024193692-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | 映恩生物制药(苏州)有限公司 | 2024-09-26 | — | — | WO | claimed |
| CN-118681035-A | Ligand drug conjugate and preparation method and application thereof | 映恩生物制药(苏州)有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-118684724-A | Linker and use thereof in ligand drug conjugates | 映恩生物制药(苏州)有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-122080121-A | Linker and use thereof in ligand drug conjugates | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4684807-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | Duality Biologics (Shanghai) Co., Ltd. (CN) | 2026-01-28 | — | — | EP | disclosed |
| CN-119300868-A | Camptothecins compound and conjugate thereof, preparation method and application thereof | 映恩生物科技(上海)有限公司 | 2025-01-10 | — | — | CN | disclosed |
| CN-119053607-A | Camptothecins compound and conjugate thereof, preparation method and application thereof | 映恩生物科技(上海)有限公司 | 2024-11-29 | — | — | CN | disclosed |
| WO-2024193692-A1 | LINKER AND USE THEREOF IN LIGAND DRUG CONJUGATE | 映恩生物制药(苏州)有限公司 | 2024-09-26 | — | — | WO | disclosed |
| CN-118681035-A | Ligand drug conjugate and preparation method and application thereof | 映恩生物制药(苏州)有限公司 | 2024-09-24 | — | — | CN | disclosed |
| CN-118684724-A | Linker and use thereof in ligand drug conjugates | 映恩生物制药(苏州)有限公司 | 2024-09-24 | — | — | CN | disclosed |